Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography in Monitoring the Response of Breast Cancer to Neoadjuvant Chemotherapy: A Meta-Analysis.

CONCLUSIONS: Analysis of the findings suggests that FDG-PET has moderately high sensitivity and specificity in early detection of responders from nonresponders, and can be applied in the evaluation of breast cancer response to neoadjuvant chemotherapy in patients with breast cancer. PMID: 23714689 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/23714689?dopt=Abstract

Source: Clinical Breast Cancer - May 25, 2013 Category: Cancer & Oncology Authors: Mghanga FP, Lan X, Bakari KH, Li C, Zhang Y Tags: Clin Breast Cancer Source Type: research